Cholesterol & Lipid
Sort by:
Scripps Health
Diabetes and Cardiovascular Disease: Medications and Interventions to Improve Outcomes
FEATURING
Athena Philis-Tsimikas
- 232 views
- June 13, 2023
- 3
Scripps Health
What’s New in Cardiology in 2023?
FEATURING
Christina Adams
- 222 views
- June 13, 2023
- 3
National Lipid Association
Treatments for Maximizing Prevention of Microvascular Complications
FEATURING
Leah Wilson
- 411 views
- March 25, 2019
- 3
New Cardiovascular Horizons (NCVH) 2017
Role of Statins and PCSK9 Inhibitors
FEATURING
Craig Walker
- 566 views
- September 18, 2017
- 2
Houston Methodist DeBakey Heart and Vascular Center
Current and Emerging Options in Lipid Management
FEATURING
Raul Santos
- 565 views
- October 20, 2021
- 3
4TS Global
Latest Clinical Trials in Cardiovascular Medicine: What Did We Learn from ISCHEMIA, ORION, COLCOT, TICO, VOYAGER PAD and Other Trials?
FEATURING
Omar Hallak
- 608 views
- March 26, 2021
- 3
AAD 2024
AAD 2024 Insights: Side Effects of Systemic Glucocorticoids (GI, Endocrine, Lipids)
FEATURING
Victoria Werth
- 585 views
- March 20, 2024
- 3
ASPC 2020 Virtual Summit on CVD Prevention
Integrating Imaging & Advanced Blood Testing for CVD Prevention/Management: How Do We Know If the Patient Is in Prediabetes Phase? Why Do Lipoproteins Become Atherogenic? What Is the Role of Non-Lifestyle Genetic Markers?
FEATURING
Arthur Agatston
- 483 views
- March 24, 2021
- 3
National Lipid Association
Lipids Clinic Management in Private Practice Setting
FEATURING
Ann Liebeskind
- 374 views
- March 25, 2019
- 3
Cardiometabolic Health Congress (CMHC)
Drawing the Line Between Primary and Secondary Cardiovascular Prevention: Too Simplistic?
FEATURING
Pam Taub
- 317 views
- July 23, 2022
- 3
ACC 2023 Conference Coverage
ACC 2023: Elevated Lp(a) - Actionable With Today's Evidence-Lipoprotein-Apheresis
FEATURING
Patrick Moriarty
- 841 views
- March 17, 2023
- 3
Novartis Cardiology
Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowering Therapy
- 1,243 views
- August 30, 2024
- 3
UCLA Health
Is Nutrition a Viable Option for Cardiovascular Risk Reduction?
FEATURING
Zhaoping Li
- 154 views
- May 10, 2024
- 3
Stephen Kopecky
CV Outcomes Trials with PCSK9 Inhibitors – SPIRE, ODYSSEY, FOURIER and EBBINGHAUS
- 749 views
- August 18, 2017
- 2
Amit Khera
ASPC Update on the New 2018 Cholesterol Guidelines Discussion
- 252 views
- January 23, 2019
- 2
Samuel Gidding
Familial Hypercholesterolemia: How to Diagnose and How to Treat? When Should We Screen for FH?
- 775 views
- December 11, 2020
- 2
University of Colorado Department of Medicine
Evaluating and Treating "Residual Risk" in ASCVD
FEATURING
Michael Blaha
- 329 views
- November 26, 2022
Cardiometabolic Health Congress (CMHC)
Familial Hypercholesterolemia: Identification and Management
FEATURING
Christie Ballantyne,
Joshua Knowles
- 316 views
- January 10, 2019
- 2
